Evidence map›Paper›PMID 34295535›Full record

ArticleBJPsych advances2021

Psychosocial stress and immunosuppression in cancer: what can we learn from new research?

Anurag K Singh, Udit Chatterjee, Cameron R MacDonald, Elizabeth A Repasky, Uriel Halbreich

Abstract read
In one paragraph

Article in BJPsych advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. The Future of Oncology in Psychiatric Medications.Journal of clinical medicine · 2025
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. WPA Scientific Sections 2020-2023: from strengthened backbone to motor of innovation.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2023
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anurag K SinghDepartment of Radiation Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Udit ChatterjeeDepartment of Radiation Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Cameron R MacDonaldDepartment of Immunology, Roswell Park Comprehensive Cancer Center, Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY, USA.ORCID 0000-0002-7402-7113
Elizabeth A RepaskyRoswell Park Comprehensive Cancer Center, Buffalo, NY, USA.ORCID 0000-0002-6703-5115
Uriel HalbreichDepartment of Psychiatry, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, NY, USA.ORCID 0000-0003-4644-809X

Funding

Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI Dean G. Tang · 1985 to 2026
$116.6M
Large heat shock proteins and their role in cancer therapyR01CA099326 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI REPASKY, ELIZABETH A, WANG, XIANG-YANG SHAWN · 2003 to 2020
$5.7M
MULTIDISCIPLINARY APPROACHES TUMOR IMMUNOLOGYT32CA085183 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI Scott I. Abrams · 2001 to 2026
$3.1M
Understanding how adrenergic signaling influences immune contexture of tumors and the efficacy of checkpoint inhibitorsR01CA205246 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI REPASKY, ELIZABETH A · 2018 to 2022
$2.8M
Targeting adrenergic stress pathways to Increase tumor sensitivity to radiation and promote development of an anti-tumor immune responseR01CA236390 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI GERBER, SCOTT ANDREW, REPASKY, ELIZABETH A · 2019 to 2023
$2.8M
The impact of chronic stress on radiation induced cell death and the anti-tumor immune responseF30CA265127 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI MACDONALD, CAMERON RIKER · 2021 to 2024
$169k
NCI NIH HHS F30 CA265127NCI NIH HHS P30 CA016056NCI NIH HHS R01 CA099326NCI NIH HHS R01 CA205246NCI NIH HHS R01 CA236390NCI NIH HHS T32 CA085183
6 · The paper itself

Abstract

It is generally believed that the physiological consequences of stress could contribute to poor outcomes for patients being treated for cancer. However, despite preclinical and clinical evidence suggesting that stress promotes increased cancer-related mortality, a comprehensive understanding of the mechanisms involved in mediating these effects does not yet exist. We reviewed 47 clinical studies published between 2007 and 2020 to determine whether psychosocial stress affects clinical outcomes in cancer: 6.4% of studies showed a protective effect; 44.6% showed a harmful effect; 48.9% showed no association. These data suggest that psychosocial stress could affect cancer incidence and/or mortality, but the association is unclear. To shed light on this potentially important relationship, objective biomarkers of stress are needed to more accurately evaluate levels of stress and its downstream effects. As a potential candidate, the neuroendocrine signalling pathways initiated by stress are known to affect anti-tumour immune cells, and here we summarise how this may promote an immunosuppressive, pro-tumour microenvironment. Further research must be done to understand the relationships between stress and immunity to more accurately measure how stress affects cancer progression and outcome.

Indexed as

Anxiety disordersdepressive disordersepidemiologyneuroendocrinologyneuroimmunology

Identifiers

PMID34295535
PMCPMC8294471

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.